Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Clinical and Experimental Rheumatology
|
July 10, 2019
Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy
Yves Piette, Maxime De Sloovere, Stien Vandendriessche, et al.
Rheumatology (Oxford, England)
|
February 5, 2016
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases
Vanessa Smith, Sam Beeckman, Ariane L Herrick, et al.
Arthritis Research & Therapy
|
September 19, 2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Seminars in Arthritis and Rheumatism
|
August 17, 2021
Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study
Els Vandecasteele, Karin Melsens, Amber Vanhaecke, et al.
Arthritis Research & Therapy
|
October 7, 2005
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
The Journal of Rheumatology
|
October 11, 2002
Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles
Jieruo Gu, Markus Rihl, Elisabeth Märker-Hermann, et al.
Acta Clinica Belgica
|
September 12, 2017
Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis
Karin Melsens, Els Vandecasteele, Ellen Deschepper, et al.
Arthritis and Rheumatism
|
December 31, 2005
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis
Fotini B Karassa, Antonella Afeltra, Ales Ambrozic, et al.
Annals of the Rheumatic Diseases
|
September 26, 2009
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial
Robert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, et al.
Clinical and Experimental Rheumatology
|
May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique
Joerg H W Distler, Suzana Jordan, Paolo Airo, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Clinical and Experimental Rheumatology
|
July 10, 2019
Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy
Yves Piette, Maxime De Sloovere, Stien Vandendriessche, et al.
Rheumatology (Oxford, England)
|
February 5, 2016
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases
Vanessa Smith, Sam Beeckman, Ariane L Herrick, et al.
Arthritis Research & Therapy
|
September 19, 2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Seminars in Arthritis and Rheumatism
|
August 17, 2021
Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study
Els Vandecasteele, Karin Melsens, Amber Vanhaecke, et al.
Arthritis Research & Therapy
|
October 7, 2005
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
The Journal of Rheumatology
|
October 11, 2002
Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles
Jieruo Gu, Markus Rihl, Elisabeth Märker-Hermann, et al.
Acta Clinica Belgica
|
September 12, 2017
Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis
Karin Melsens, Els Vandecasteele, Ellen Deschepper, et al.
Arthritis and Rheumatism
|
December 31, 2005
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis
Fotini B Karassa, Antonella Afeltra, Ales Ambrozic, et al.
Annals of the Rheumatic Diseases
|
September 26, 2009
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial
Robert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, et al.
Clinical and Experimental Rheumatology
|
May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique
Joerg H W Distler, Suzana Jordan, Paolo Airo, et al.
Page
of 11